Request Deal Involvement

Mallinckrodt to acquire Sucampo Pharmaceuticals for $1.2bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Jefferies & Company

financial advisors

Jefferies & Company

Cooley

legal advisors

Cooley

Wachtell Lipton Rosen & Katz

legal advisors

Wachtell Lipton Rosen & Katz

Deutsche Bank

financial advisors

Deutsche Bank

or

Principals

SUCAMPO PHARMACEUTICALS

target

SUCAMPO PHARMACEUTICALS

MALLINCKRODT PLC

bidder

MALLINCKRODT PLC

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Mallinckrodt to acquire Sucampo Pharmaceuticals for $1.2bn.